Biography

Certifications:

  • American Board of Nuclear Medicine, 1997
  • Certification Council of Nuclear Cardiology, 1998
  • Maintenance of Certification Exam, 2007
  • Certification in Coronary CTA Interpretation, 2008

Education

Medical School
Faculty of Medicine, The University of Khartoum, Khartoum, Sudan, 1986
Internship
Internal Medicine, Hahnemann University Hospital, Philadelphia, PA., 1995
Residency
Nuclear Medicine, Baylor College of Medicine, Houston, Texas, 1997
Fellowship
Nuclear Medicine, Baylor College of Medicine, Houston, Texas, 1998

Research Information

**Faculty profiles will only highlight current information (the last three years). Please see the faculty’s CV for more information.

 

GRANTS

  1. P.I.: Isis Gayed
    Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively.HSC-MS-16-0015
    Amount: $6000 3/2016 – present
  2. P.I.: Paul Schultz
    Co-Investigator: Isis Gayed
    Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study
    HSC-MS-15-0922
    Amount: $4000/patient 2016 – 2017
  3. P.I.: Beth Scholtz
    Co-Investigator.: Isis Gayed
    Treatments Against Rheumatoid Arthritis and Effect on FDG PET-CT: The TARGET Trial
    HCS-MS-17-0082
    Novartis Funded 2/2017-present
  4. P.I.: Joseph Lucci
    Co-Investigator: Isis Gayed
    A randomized phase II trial of radiation therapy and cisplatin alone or in combination with intravenous triapine in women with newly diagnosed bulky stage IB2, stage II, IIIB, or IV A cancer of the uterine cervix or stage II-IV A vaginal cancer.
    HSC-MS-16-0320
    Funded by the National Cancer Institute 1/19/2018-present.
  5. P.I.: Ernest Conrad
    Collaborator: Isis Gayed
    A Phase 2, randomized, Double-Blind, Placebo-Controlled Efficacy and safety study of Palovarotene in subjects with multiple osteochondromas.
    HSC-MS-18-0597 10/26/2018-present
    Funded by Clementia Pharmaceuticals, Inc.
  6. P.I.: Absalon Gutierrez
    Co-Investigator: Isis Gayed
    GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response.
    HSC-MS-19-0787
    Funded by NIH 7/1/2019-6/30/2022

UNFUNDED

  1. Principle Investigator: Identification of pattern(s) of abnormalities using DaTscan in patients with essential tremor. HSC-MS-17-0365, 04/2017
  2. Co-Investigator: Compare the sensitivity and specificity of Leucine analog F18- Fluciclovine PET scan with bone scan to detect prostate cancer bony metastases.HSC-MS- 8/2017
  3. Co-Investigator: Lung quantification scintigraphy in the lung transplant patients. : Correlation of patient symptoms with development of defects. HSC-MS-19-0002, 12/2018
  4. Principal Investigator: Evaluation of brain stimulation on PET-CT scans in patients with depression. HSC-MS-19-0003, 3/2019
  5. Principal Investigator: Identification of micrometastases from pre-operative lymphoscintigraphy in breast cancer patients. HSC-MS-19-0931, 11/2019.
  6. Principal Investigator: The value of repeat Ga-68 Dotatate PET-CT imaging in follow up of neuroendocrine tumors. HSC-MS-19-1034, 10/2019

Publications

Publication Information

**Faculty profiles will only highlight current information (the last three years). Please see the faculty’s CV for more information.

 

Refereed Original Articles in Journals:

  1. Usha A. Joseph, Ron J. Karni, David Q. Wan, Isis W. Gayed. Limited PET/CT– A New Concept in Follow-up of Head and Neck Cancer Patients. Journal of Molecular Medicine and Clinical Applications. 2(1):1-5, June 2018.
    https://sciforschenonline.org/journals/molecular-biology-medicine/article-data/JMMCA-2-111/JMMCA-2-111.pdf
  2. Isis Gayed, Vivian Salama, Lydia Dawood, Steven Canfield, David Wan, Chunyan Cai, Usha Joseph, Robert Amato. Can bone scans guide therapy with Radium 223 Dichloride for patients with castrate resistant bony metastases. Cancer Manag Res. 2018 Sep 7;10:3317-3324.
  3. Susana Calle, Lydia Dawood, Niroj Tripathee, Chunyan Cai, Harleen Kaur, David Wan, Henry Ibekwe, Isis Gayed. Identification of patterns of abnormalities seen on DaTscan SPECT imaging in patients with non-Parkinson movement disorders. Reports in Medical Imaging. 12:9-15, July 2019.
  4. Rashad Johnson, Grace Rizk, Omotola Hope, Harleen Kaur, Henry Ibekwe, Monica Atta, Isis Gayed. PET CT and PET-MRI Fusion: Can they help predict surgical outcome in Epilepsy patients?. Journal of Neuroadiology. Oct 22, 2019. https://doi.org/10.1177/1971400919881464

Scientific Session Presentations at National/International Meetings:

  1. Gayed, I., Is Cholecystokinin Administration During Hepatobiliary Imaging A Physiologic Test? SNMMI Annual Meeting, Denver, June, 2017
  2. Gayed I, Improving Hepatobiliary Imaging As A Physiologic Test with Superior Clinical Outcomes, SNMMI Annual Meeting, Philadelphia, June, 2018

Other Scientific Presentations in Different Institutions:

  1. Thyroid Cancer Imaging in Nuclear Medicine, Endocrine Conference, UT-Health, Houston, TX April, 2019
  2. Predicting Surgical Outcomes in Patients with Refractory Seizures Using PET-CT and PET-MRI Fused Images. Frist Annual Research Retreat. Department of Interventional and Diagnostic Imaging, UT-Health, Houston, TX Feb, 2020

Scientific Exhibits:

  1. Is Cholecystokinin Administration During Hepatobiliary Imaging A Physiologic Test? Society of Nuclear Medicine 64th Annual Meeting, Denver, CO June 2017.
  2. Quantification of Tc-99m MAA liver perfusion as a predictive of tumor response to Yittrium 90 spheres. Electronic scientific exhibit, ARRS 118th meeting, Washington D.C. Apr, 2018

 

 

 

Honors and Awards

**Faculty profiles will only highlight current information (the last three years). Please see the faculty’s CV for more information.